Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply

Quick Summary:

GSK Plc, Sanofi and CSL Ltd.secured $72 million from the United States government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to several human infections that have raised concerns about further spread.

Under the agreement, GSK, Sanofi and CSL will also make additional bulk vaccine ingredients matched to circulating strains of bird flu.

The Atlanta-based public health agency expects to have results from these tests in mid-to-late October, according to Demetre Daskalakis, the director of the CDC’s National Center for Immunization and Respiratory Diseases.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Bloomberg News

Category: BusinessStartups

Markets: PhilippinesFinlandUnited States

Topics: Response Vaccine Bird Health Outbreak O’connell Sanofi Vaccines Million Supply Human

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-06 @ 12:47:36 (12 hours ago)

News Timezone: GMT +8:00

News Source URL: businessmirror.com.ph

Language: English

Article Length: 687 words

Reading Time: 4 minutes read

Sentences: 27 lines

Sentence Length: 26 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Mirror

News ID: 22909918

View Article Analysis

About Business Mirror

Main Topics: BusinessStartups

Official Website: businessmirror.com.ph

Update Frequency: 60 posts per day

Year Established: 2005

Headquarters: Philippines

News Last Updated: 8 hours ago

Coverage Areas: Philippines

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #37

Publisher Details

Frequently Asked Questions